Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01624350
Other study ID # COVPERP0200
Secondary ID
Status Completed
Phase N/A
First received June 15, 2012
Last updated November 29, 2016
Start date September 2012
Est. completion date June 2015

Study information

Verified date November 2016
Source Medtronic - MITG
Contact n/a
Is FDA regulated No
Health authority United Kingdom: Medicines and Healthcare Products Regulatory AgencyItaly: Ethics CommitteeDenmark: Ethics Committee
Study type Observational

Clinical Trial Summary

This will be a prospective, multi-center, post-market, single arm observational study to collect clinical outcome data on the use of Permacol™ Collagen Paste in the treatment of anorectal fistulas.

The subjects will have baseline and day of surgery visits performed, and then subjects will return to the investigator for evaluation of defect and safety related morbidities at follow up visits scheduled at 1 month, 3 months, 6 months and 12 months post-surgery.


Description:

The study will enroll 100 subjects at up to 10 centers throughout the European Union. The expected duration of the enrollment period is approximately 9 months. The duration of each subject's participation in the study will be approximately one year. However, at sites where the routine follow-up period is greater than one year, subjects may be followed for up to 36 months at their surgeon's discretion if they agree to it.


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date June 2015
Est. primary completion date December 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Key Inclusion Criteria:

1. Male or female subjects age 18 or older

2. Subjects diagnosed with a solitary tract anorectal fistula of cryptoglandular origin

Key Exclusion Criteria:

1. History or suspicion of Inflammatory Bowel Disease (i.e.Crohn's Disease, Ulcerative Colitis)

2. Subjects with secondary tracts, horseshoe fistulas, ano/recto-vaginal fistulas, or rectourethral fistulas

3. Indication of an actively infected fistula/abscess (acute sepsis)

Study Design

Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Device:
Permacol collagen paste
Collagen paste intended to reinforce soft tissue where filling is required such as to repair fistulas, including anal and rectal fistulas.

Locations

Country Name City State
Denmark Aalborg Hospital Aalborg
Denmark Aarhus University Hospital Aarhus C
Italy Casa di Cura PIO X Milan
Italy AO S.Maria degli Angeli, S.S.D. Degenze Brevi 1^ 2^ Chirurgia Ginecologia e Urologia Pordenone
Italy University of Rome Tor Vergata, Surgery-Policlinico Tor Vergata Rome
United Kingdom Ninewells Hospital & Medical School Dundee
United Kingdom Leicester General Hospital Leicester
United Kingdom King's College Hospital London
United Kingdom Whipps Cross University Hospital London
United Kingdom Royal Victoria Infirmary New Castle

Sponsors (1)

Lead Sponsor Collaborator
Medtronic - MITG

Countries where clinical trial is conducted

Denmark,  Italy,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Fistula Healing in Patients at 6 Months Following Surgery Clinical assessment of fistula healing as defined by 1) no discharge from the fistula and 2) the external opening has closed. 6 months No
Secondary Fistula Healing in Patients at 3 and 12 Months Following Surgery Clinical assessment of fistula healing as defined by 1) no discharge from the fistula and 2) the external opening has closed. 3 months and 12 months No
Secondary Participant Response to Quality of Life EQ-5D Questionnaire Quality of Life by EQ-5D questionnaire is a standardized measure of health status. It is a 25-item questionnaire that measures quality of life of patients pre and post surgery in the following categories: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each category has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems. Baseline, and 3 months, 6 months and 12 months post op No
Secondary Fecal Incontinence Fecal Incontinence change from baseline as measured by CCF-FI questionnaire. This questionnaire is a summed score of 5 individual parameters (frequency of incontinence to gas, liquid solid, of need to wear pad, and of lifestyle changes) It is measured from a patient-completed questionnaire with each parameter given a score from 0 to 4, with 0 indicating its absence and 4 indicating daily presence. These values are added to give a total score ranging from 0 to 20 (0 indicating perfect control, 10-15 indicating moderate incontinence, and greater than 15 indicating severe incontinence. 3 months, 6 months and 12 months No
Secondary Patient Satisfaction Between the First and Last Post-operative Visit Patient satisfaction questionnaire included questions regarding fecal continence and overall satisfaction with the operation. Between the first and last visits No
Secondary Pain Pain by VAS (Visual Analog Scale) VAS is a 10-point scale with 0 being no pain and 10 being the most pain. Baseline, 1 month, 3 months, 6 months and 12 months Yes